Jurgen Mullberg
About Jurgen Mullberg
Jurgen Mullberg is the Associate Director at Bristol Myers Squibb in Devens, MA, with a background in Life Sciences and Biology from Rheinisch-Westfälische Technische Hochschule Aachen, and extensive experience in protein therapeutics and antibody engineering.
Current Role at Bristol Myers Squibb
Jurgen Mullberg is currently serving as an Associate Director at Bristol Myers Squibb in Devens, MA. In this role, he leads the Process Analytics & Method Characterization group within Bioprocess Technology-MST. He supports the global manufacturing network by acting as a Viral Safety Subject Matter Expert, focusing on adventitious agent control of cell substrates and manufacturing processes. Mullberg also evaluates opportunities for new rapid methods for the detection of adventitious viruses, such as next-generation sequencing (NGS).
Previous Roles and Experience
Before joining Bristol Myers Squibb, Jurgen Mullberg worked at Novartis as a Principal Scientist from 2010 to 2014 in Cambridge, MA. Prior to that, he was the Associate Director of Research at Dyax, where he worked from 2000 to 2009, also in Cambridge, MA. During his time at these organizations, he gained valuable experience in both discovery and development of therapeutic proteins, subunit vaccines, and the generation and characterization of stable CHO cell lines using DHFR and GS-based technology platforms.
Educational Background
Jurgen Mullberg studied at Rheinisch-Westfälische Technische Hochschule Aachen, where he pursued studies in Life Sciences/Biology and achieved a PhD. This educational background laid the foundation for his extensive career in the biopharmaceutical industry.
Publications and Patents
Jurgen Mullberg has authored and co-authored over 40 articles published in peer-reviewed journals. He is also the inventor on more than 10 US patents related to protein therapeutics and antibody engineering. His contributions to the scientific community are well-documented and have had a significant impact on his field.
Expertise in Autoimmune Diseases and Inflammation
Jurgen Mullberg has a strong background in studying molecular mechanisms of autoimmune diseases and inflammation. This expertise has been instrumental in his work on both discovery and development of therapeutic proteins and subunit vaccines. His in-depth understanding of autoimmune diseases and inflammation processes adds valuable insight to his research and professional endeavors.
Leadership and Team Collaboration
Throughout his career, Jurgen Mullberg has successfully led diverse international teams and collaborated with various business units involved in technology and product development and commercialization. This includes working with Legal, Quality, and Regulatory departments. His leadership and collaborative skills have been essential in bringing innovative biopharmaceutical products to market.